Patents Assigned to TEEWINOT LIFE SCIENCES CORPORATION
  • Publication number: 20220213428
    Abstract: The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Applicant: TEEWINOT LIFE SCIENCES CORPORATION
    Inventors: Richard PEET, Malcolm J. KAVARANA, Mingyang SUN, Peter C. MICHELS, John D. RABENSTEIN, C. Seth PEARSON, Geoffrey M. FOX
  • Patent number: 11319525
    Abstract: The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: May 3, 2022
    Assignee: TEEWINOT LIFE SCIENCES CORPORATION
    Inventors: Richard Peet, Malcolm J. Kavarana, Mingyang Sun, Peter C. Michels, John D. Rabenstein, C. Seth Pearson, Geoffrey M. Fox